First Opinion Podcast

Every four years, someone says “This is the most important election ever.” But it’s hard to question the long-term impact Election Day 2024 will have — from the top of the ballot on down. So the first five episodes of the fall 2024 season of the “First Opinion Podcast” will grapple with the campaign and its intersection with health, medicine, and the life sciences. I’ll speak with experts on issue...

For scientists and medical professionals well versed in the safety and effectiveness of vaccines, it is often too easy to write off the concerns of people who fear them, or feel they have been injured by them. But vaccine expert Kizzmekia S. Corbett-Helaire argues that professionals should be more empathetic when it comes to listening to these concerns, and that understanding them may help develop...

In a special edition of the "First Opinion Podcast," STAT executive editor Rick Berke and senior writer Helen Branswell interviewed the country’s former top infectious disease expert about some of the insights and revelations from his new memoir, "On Call: A Doctor's Journey in Public Service." Conversation topics include when Fauci knew that Covid-19 was a real threat; when AIDS activist Larry Kr...

While the bogus science of eugenics — the idea that the idea that the human race can be improved through selective reproduction — has been nearly universally discredited, remnants of this belief system are still alive and well in modern research. One of the most glaring examples of this is the work of academic psychologist Richard Lynn. Two recent First Opinion authors, Rebecca Sear and Dan Samoro...

It has been two years since the Supreme Court made the historic decision to overturn Roe v. Wade, which had protected the right to abortion in the United States. Since then, 21 states have severely restricted or outright banned access to abortion care. Diana DeGette, a Democrat who has represented Colorado's 1st Congressional District in the House of Representatives since 1997, and who has co-chai...

Millions of people around the world are living with long Covid, a potentially debilitating and medically perplexing condition. Rachel Hall-Clifford is one of them. As a medical anthropologist, she’s well suited to understand the condition. But as a mother, wife, friend, researcher, and teacher, it drags her down, just as it does so many others.

This week's episode of the "First Opinion Podcast" explores the issue of medical debt, which burdens as many as 40% of U.S. adults. They collectively owe more than a whopping $200 billion. Many organizations and even federal and state governments have established debt relief programs to tackle the problem. Such programs make intuitive sense. But they may not work and, in some cases, could even har...

The medications methadone and buprenorphine are considered “gold standards” for the treatment of opioid use disorder. They are so effective, in fact, that they are considered nearly curative for people that use them as prescribed. Unfortunately, a multitude of social and physical barriers to access means that only about 20% of people that need them have access to these treatments. That access is e...

When it comes to childhood and young adulthood, most people in the U.S. think of carefree times of life with few major responsibilities. But for a small subset of young people, these years also mean caring for loved ones. Harvard medical students Kimia Heydari and Romila Santra both have firsthand experience being young caregivers, and spoke with "First Opinion Podcast" host Pat Skerrett about the...

If you ask a chatbot how to cause a pandemic, it will suggest the 1918 influenza virus, according to researcher Kevin Esvelt. It will even tell you where to find the gene sequences online and where to purchase the genetic components. Esvelt is a biologist and MIT professor whose work has included altering the genes of mice to prevent the spread of Lyme disease. In a recent First Opinion essay, he...

University of Pennsylvania oncologist and researcher Ezekiel Emanuel and Matthew Guido, a project manager in the Healthcare Transformation Institute, discuss their original research on tuition-free programs with former host Pat Skerrett, who is filling in while Torie Bosch is on maternity leave. They make the case that medical school debt is only one of many factors that influence new doctors to c...

James Sulzer has spent his life tinkering with tools that help patients with neurological conditions. But after his 4-year-old daughter sustained a traumatic brain injury in 2020, his eyes were opened to how much his field was missing about the real experiences of families dealing with recovery. This week, Sulzer speaks with host Torie Bosch about the importance of centering patients in research a...

Back in February, physician and advocate Joel Zivot wrote a First Opinion essay shortly after Kenneth Smith was executed using nitrogen gas in Alabama. In “A new Louisiana capital-punishment bill would fundamentally alter physician licensing,” Zivot argues against proposed bills in both Kansas and Louisiana that would allow “death by hypoxia.” Not only is this type of death cruel and painful, he a...

De-Shaine Murray is working at the cutting edge of neurotechnology. As a postdoctoral fellow at Yale, he is developing a device to monitor the brain following traumatic brain injury or stroke. He is also trying to fight the long legacy of racism in neuroscience. He sees a direct line from racist pseudoscience like phrenology to disparities in neuroscience today, like how the texture of Black peopl...

Manil Suri and Daniel Morgan are an unusual team: Manil is a mathematics professor and author, while Daniel is a physician and professor of epidemiology, public health, and infectious diseases. But they recently teamed up for a First Opinion essay, “Diagnostic tests for rare conditions present a mathematical conundrum,” in which they write about how the more rare a disease ease, the more likely a...

Before he joined Congress, Rep. Raul Ruiz, a Democrat from California, worked in another chaotic environment: the emergency department. Today, he says, he tries to bring his background in medicine and public health to policymaking. In particular, he has turned his attention to a shortage of infectious disease physicians that threatens U.S. preparedness for the next pandemic. Our conversation was b...

When Prozac first entered the psychiatry scene in in the late 80s, the profession was still Freud's territory. Meaning: it was considered by many a failure to take medication to cure depression. But that was all about to change, with early stewards like psychiatrist Peter Kramer, who refused to shy away from the new drug's potential. These days, he says that people take for granted all of the prog...

Fifteen years ago, Mara Buchbinder and colleagues came up with the concept of the “patient in waiting.” The concept described a new category of patients created by cutting-edge testing for conditions that may never appear. The patient in waiting was, quite literally, someone who was waiting to see if they would become ill. Mara's husband, Jesse Summers, was diagnosed with metastatic colon cancer i...

This week, medical student Amelia Mercado and her professor J. Wesley Boyd talk about the stressors of medical training, privacy concerns within academic institutions, and how high insurance costs affect access to mental health care. The conversation is based on their co-authored First Opinion, "How medical schools are failing students who need mental health care."

The term "excited delirium" has been used for years by law enforcement and other first responders, including health care workers, to describe people who exhibit behavior that is considered "out of control." This diagnosis has been applied again and again, even posthumously, as a justification for extreme and sometimes deadly, interventions by law enforcement. It came up most recently in the trials...

Have you ever taken phenylephrine for a stuffed-up nose and then felt better? If so, you might have been perplexed when Food and Drug Administration experts recently said that that the drug — which is in some versions of DayQuil, Sudafed, and other medicines — is no more effective than a placebo. But to Michael H. Bernstein, an assistant professor of diagnostic imaging at the Warren Alpert Medical...

In just two weeks, the brutality of the Israel-Hamas conflict has shocked the world. But one of its most heartbreaking aspects — the destruction of the already-struggling health care system in Gaza — is part of a decades-long pattern during war both in the region and around the world. Leonard Rubenstein is a distinguished professor of practice at the Johns Hopkins Bloomberg School of Public Health...

After physically debilitating cancer treatment, Laurie Brunner encountered another medical hurdle: She had developed lymphedema that required surgery, but her BMI was over the cutoff. To receive the necessary treatment, she would have to lose weight. I spoke with Laurie and her physician Jody Dushay about how the ongoing shortages of GLP-1 medications are creating logistical and medical problems....

We're popping into your feed on a Sunday because we wanted to share an episode of The Nocturnists: Post-Roe America. You may have already heard the First Opinion Podcast interview with Ali Block, an abortion provider and executive producer of The Nocturnists, and Nikki Zite, an OB/GYN in Tennessee. (If you haven't listened yet, please do!) On this episode of The Nocturnists, you'll hear more from...

Physicians Alison Block and Nikki Zite knew what they were getting into when they became abortion providers early in their medical training. Family planning has long been a politicized, divisive area of medicine. And even though they knew that Roe v. Wade — the 1973 Supreme Court case that protected abortion access across the country — was being threatened, it still hit them hard when that ruling...